Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2048.77 (Glytoucan)

Id:edbb1c57-96f9-5f7e-8148-1f74fd0231b5

Glytoucan:G62725PI

Results found

Linked to

	Label	Description
	2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000009 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G24715YN-GLYCOSEQ00118599 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G62725PI-GLYCOSEQ00183554 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 has canonical residue n-glycan b-d-glcpnac 7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G32902JQ-GLYCOSEQ00131540 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G35912PE-GLYCOSEQ00106247 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000009 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G24715YN-GLYCOSEQ00118599 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G62725PI-GLYCOSEQ00183554 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 has canonical residue n-glycan b-d-glcpnac 7

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G32902JQ-GLYCOSEQ00131540 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 has glycosequence GLYGEN.GLYCOSEQUENCE:G35912PE-GLYCOSEQ00106247 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2048.77 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000021 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.